Repaglinide is an oral medication used to treat type 2 diabetes. It belongs to a class of drugs called meglitinides, which work by stimulating the pancreas to produce more insulin. This helps to lower blood sugar levels in people with type 2 diabetes.
Repaglinide can effectively lower blood sugar levels in people with type 2 diabetes.
It is a rapid-acting medication, which means it starts working quickly after being taken.
It can be taken before meals, which makes it a convenient option for people who have irregular meal times.
Common side effects include headache, nausea, diarrhea, and stomach pain.
Low blood sugar (hypoglycemia) can occur, especially if repaglinide is taken with other diabetes medications or if the person’s diet or exercise routine changes.
Repaglinide may also increase the risk of heart attack or stroke, especially in people with a history of heart disease or stroke.
It may also cause weight gain and fluid retention.
It can also cause allergic reactions.
People with liver or kidney disease should not take repaglinide.